Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 25% share buyback. 25% dividends, 50% PTSC cash on hand, liquidity. eom

25% share buyback. 25% dividends, 50% PTSC cash on hand, liquidity. eom

posted on Dec 11, 2006 11:06AM
Share
New Message
Please login to post a reply